Printer Friendly

CELOX CORPORATION ANNOUNCES APPOINTMENT

 CELOX CORPORATION ANNOUNCES APPOINTMENT
 MINNEAPOLIS, July 7 /PRNewswire/ -- Wanda L. Thorpe has been


appointed to the new position of director of sales at Celox Corporation (NASDAQ: CELX), effective immediately, it was announced by Milo Polovina, president and chief executive officer of the bio-tech company.
 Thorpe will be responsible for developing, implementing and supervising the company's direct-sales force.
 Thorpe has over eight years experience in the pharmaceutical industry and most recently was district sales manager for SmithKline Beecham. "We are pleased to have someone with her sales and management experience join our Celox team," Polovina said.
 Thorpe received a master's degree in Public Health/Nutrition from the University of Minnesota.
 Celox Corporation is a developer, manufacturer and marketer of innovative serum-free cell biology products. The company's shares are traded on NASDAQ under the symbol CELX.
 -0- 7/7/92
 /CONTACT: Milo R. Polovina of Celox, 612-933-2616; or George W. Fredericks of Financial Communication Specialists, 612-590-7489, for Celox/
 (CELX) CO: Celox Corporation ST: Minnesota IN: MTC SU: PER


AL -- MN002 -- 6931 07/07/92 10:45 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 7, 1992
Words:175
Previous Article:TSI CORPORATION ANNOUNCES BOARD CHANGES
Next Article:APPLIED BIOSCIENCE INTERNATIONAL APPOINTS TIMONEY SENIOR VICE PRESIDENT, AMUNDSEN CHIEF FINANCIAL OFFICER
Topics:


Related Articles
CELOX ANNOUNCES MARKETING AGREEMENT
CELOX CORPORATION FILES TRADEMARK SUIT AGAINST FORMER ENDOTRONICS
CELOX CORPORATION BOARD AUTHORIZES STOCK REPURCHASE
CELOX CORPORATION HIRES SALES MANAGER
CELOX CORPORATION NAMES SALES AND MARKETING VICE PRESIDENT
CELOX CORPORATION INCREASED SALES IN FIRST QUARTER
CELOX CORPORATION AND AMERICAN TYPE CULTURE COLLECTION TO OFFER SERUM FREE CELL LINES
CELOX CORPORATION ANNOUNCES 1994 FINANCIAL RESULTS
CELOX LABORATORIES, INC. SIGNS DISTRIBUTION AGREEMENT WITH ICN PHARMACEUTICALS, INC.
CELOX LABORATORIES, INC. ANNOUNCES RECEIPT OF OFFICE ACTION FROM U.S. PATENT AND TRADEMARK OFFICE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters